








































Peroxisome proliferator-activated receptor-γ coactivator-
1α (PGC-1α) is a transcription factor controlling many 
aspects of oxidative metabolism, including mito-
chondrial biogenesis, adaptation, respiration, adaptive 
thermogenesis, gluconeogenesis and oxidative 
phosphorylation [1, 2]. Signalling for mitochondrial 
biogenesis (MB) is activated by PGC-1α and involves 
the expressionof several transcription factors, resulting 
in the upregulation of proteins encoded by both nuclear 
and mitochondrial genomes. Oxidative stress from the 
generation of reactive oxygen species  (ROS)  has  often  
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been cited as toxicants, and is believed to originate from 
mitochondria. Many neurodegenerative conditions have 
been shown to originate from compromised number, 
morphology and function of mitochondria. PGC1α has 
previously been reported to play a protective role against 
neurodegenerative conditions such as Alzheimer’s 
disease and is known to respond to ROS by the induction 
of many ROS-detoxifying enzymes, including superoxide 
dismutase, Gpx1and γ-glutamylcysteine, regulating the 
biosynthesis of glutathione. Moreover, Ca2+ and ROS 
have been shown to regulate mitochondrial biogenesis by 
activating PGC1α, leading to an increase in 




























this hormetic  response  is controlled by a cell‐tolerated  increase of PGC1α expression, which  in  turn  induces a balanced
expression of fusion/fission genes by binding to their promoters and implying its direct role in regulation of MD. However,
dysregulation of PGC1α expression through either stable downregulation or overexpression, renders cells more susceptible
to  lead  insult  leading  to  mitochondrial  fragmentation  and  cell  death.  Our  data  provide  novel  evidence  that  PGC1α
expression is a key regulator of MD and the maintenance of tolerated PGC1α expression may offer a promising strategy for
neuroprotective therapies. 
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Growing evidence suggests that the delicate equilibrium  
between mitochondrial fission and fusion is vital for 
many mitochondrial functions including metabolism, 
energy production, Ca2+ signalling, ROS production and 
apoptosis. In many types of neurodegenerative diseases, 
a significant reduction in the levels of fusion proteins 
optic atrophy-1 (Opa-1), mitofusin-1 (Mfn-1) and 
mitofusin-2 (Mfn-2) as well as the fission protein 
dynamin-related protein-1 (Drp-1) is reported, as well 
as an increase in the level of the fission related protein-1 
(Fis-1) [5].  
 
A number of signalling processes relating to 
mitochondrial, nuclear and inter-organelle communica-
tion, have been shown to be sensitive to ROS. Upon 
oxidative stress, the mitochondria and the endoplasmic 
reticulum critically contribute to apoptosis induction via 
a signalling pathway that establishes a feedback loop by 
releasing Ca2+ from the ER which in turn activates the 
mitochondria for apoptosis [6]. 
 
The majority of mechanisms proposed for 
neurotoxicant-induced cellular damage converge on 
mitochondrial dysfunction and energy deprivation 
[7].The integrity of this organelle is vital in the context 
of neurodegeneration due to the high-energy demands 
of dopaminergic neurons as a result of their unusually 
long axons [8]. This generates a need for the stringent 
regulation of mitochondrial biogenesis, function and 
dynamics in such cells. Disruption of any of these 
processes can contribute to neurodegenerative disorders 
[9] such as Parkinson’s [10], Alzheimer’s [11] and 
Huntington’s disease [12]. However, no study has fully 
elucidated a link between mitochondrial biogenesis and 
dynamics in neurotoxicity, highlighting the need for a 
thorough investigation into PGC1α’s role in those 
processes in the context of neurological disorders. 
 
Chronic exposure to the environmental neurotoxicant 
lead is believed to be associated with neurodegeneration 
[13]. While it has been proposed that there is an 
association between chronic lead exposure and risk of 
Parkinson’s disease (PD) [14, 15], the exact mechanism 
is not fully understood. Exposure to lead induces 
oxidative stress in the form of ROS in a variety of 
different tissues [16, 17] and also induces Ca2+ release 
from the ER in hippocampal neurons [18]. However, 
evidence is lacking with regards to the mechanism of 
neuronal damage and whether its induction in 
chronically exposed individuals is due to an increased 
production of ROS or disruption of calcium 
homeostasis or both.  
 
In this study we investigated the role of PGC1α as a 
regulator of both mitochondrial biogenesis and 
dynamics in vitro and in vivo in the context of lead-
induced neurotoxicity. Strikingly, the role of PGC1α 
was found to be equivocal. While a modest increase of 
PGC1α expression provides a neuroprotective role, 
dysregulation of expression either by knockdown or 
overproduction is non-tolerated, leading to 
neurotoxicity. Our data showed a significant increase of 
expression of a mitochondrial fission protein, DRP1, in 
both,neuronsin the rat substantia nigra (SN) and 
adopaminergic (DA) neuronal N27 cell line. SN cells 
showed an adaptive response to lead exposure by 
increasing the transcript levels of PGC1α, its target 
genes, regulating mitochondrial biogenesis, and 
mitochondrial fusion- and fission-related genes. ChIP 
and QPCR analysis revealed that PGC1α directly 
regulates DRP1expression by binding to its promoter. 
Our data provides strong evidence that PGC1α is 
directly involved in the cellular response to lead by 




Exposure to lead induces mitochondrial dysfunction, 
energy depletion and subsequent apoptosis of 
dopaminergic neurons 
 
N27 cells, derived from rat mesencephalon, were used 
to evaluate the effect of lead on mitochondrial function. 
Cells were treated with a range of lead (II) acetate 
concentrations over a period of 48 hours. Cells stained 
with MitoSOX and analyzed by flow cytometry 
revealed a 25% increase in mitochondrial superoxide at 
5 µM and 100 µM concentrations and almost a 100% 
increase at 500 µM (Fig. 1A). DiOC6(3), a selective 
mitochondrial dye, and propidium iodide (PI) staining 
revealed that lead causes mitochondrial membrane 
depolarization and neuronal cell death, which was much 
more marked at 500 µM than at 5 or 100 µM (Fig. 1B, 
C). PARP cleavage analysis (Fig. 1D) confirmed this, 
with the effect being far more pronounced at the highest 
lead concentration. At 5µM and 100µM, effects on 
mitochondrial dysfunction and cell death were similar 
(Fig. 1A-D). Apoptotic cell death was confirmed by an 
increased activation of caspases3/7 and caspase 8 in N27 
cells exposed to 100µM and 500µM lead (Supplementary 
Figure1-S-1, A-a and b). Morphological characteristics of 
apoptotic cells, including condensed nuclei, were also 
evident in cells treated with 500µM lead (Supplementary 
Figure1-S-1, B and C). Morphological changes in the 
cells were apparent only at higher concentrations than 
changes in molecular markers of apoptosis, most likely 
reflecting the temporal engagement of the respective 
hallmarks of apoptosis. 
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Mitochondrial function was assessed by Seahorse XF24 
analysis allowing for the measurement of a number of 
parameters including mitochondrial basal respiration, 
ATP production, oxygen consumption rate (OCR), 
maximum respiratory capacity and mitochondrial spare 
respiratory capacity. While a reduction in basal 
respiration was observed in cells treated with 100 and 
500 µM lead (Fig. 1E), this was not statistically 
significant. There was a concentration-dependent 













































lead concentration causing a statistically significant  
(P<0.01) decrease of more than 50%. Proton leak was not 
significantly affected by lead treatment (Fig. 1G). 
Maximal respiration decreased in a concentration-
dependent manner (Fig. 1H). Interestingly, mitochondrial 
reserve capacity levels were very low across all of the 
lead-treated cells (P<0.01) including 5 µM, a 
concentration which did not have a significant impact on 
other aspects of mitochondrial function investigated with 















































Figure 1. Exposure  to  lead  induces mitochondrial dysfunction and subsequent apoptosis of N27 dopaminergic
neurons. Cells were  incubated  for 48‐hours with  lead  acetate,  at  the  concentrations  shown.  (A) Mitochondrial  superoxide
levels were measured using MitoSOX  staining  followed by FACS analysis.  (B) The effect of  lead  treatment on mitochondrial
membrane potential  (MMP)  loss was detected by DiOC6(3).  (C) Analysis of cell death measured by propidium  iodide  (PI).  (D)
Western  blot  analysis  of  PARP  cleavage  (PARP  to  PARPc)  following  lead  exposure.  Profiles  of  different  parameters  of
mitochondrial function (E‐I) were determined using Seahorse XF24 Analyser.  *P<0.05, **P<0.01, ***P<0.001, n=3; mean ± SE. 
  
















































































































with  lead  acetate  at  the  concentrations  shown.  (A,B)  qRT‐PCR  and western  blotting measurement  of mRNA  and  protein
expression  levels, respectively of Pgc1α  in N27 cells treated with  lead for 48‐hours. (C)   mRNA  levels of Pgc1α target genes
(Tfam, Nrf1)inN27  cells  treated with  lead  for  48‐hours.(D)N27  Pgc1αmRNA  levels  after  3‐hours  lead  treatment.(E)  Pgc1α
mRNA levels and (F) colony formation in N27 cells with stable downregulation of PGC1α. (G) Mitochondrial superoxide levels
were measured  in shPGC1α cells using MitoSOX staining and   (H) the effect of  lead treatment on mitochondrial membrane
potential loss in shPGC1α was detected by DiOC6(3) in N27 cells treated with lead for 48‐hours. (I,K) Confocal imaging analysis
of mitochondrial morphology in wild type PGC1α and in overexpressed PGC1α N27 cells (↑Pgc1α) was investigated using Mito
Tracker  and  DAPI  staining  recorded  by  fluorescence microscopy.  (J)  qRT‐PCR  analysis  of  Pgc1α  in  N27  cells  expressing
exogenous Pgc1α versus↑Pgc1α cells, treated with lead for 48‐hours.*P<0.05, **P<0.01, n=3; mean ± SE. 
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PGC1α protects DA neurons from neurotoxic insults 
from lead 
 
Real-time QPCR and protein expression analyses were 
performed to investigate the expression of Pgc1α and its 
downstream targets, which regulate mitochondrial 
biogenesis, in lead-treated N27 cells. Interestingly, only 
the 100 µM treatment with lead for 48 h caused a 
significant increase of Pgc1α expression, at both the 
RNA and protein levels (Fig. 2A, 2B). Downstream 
targets of PGC1α, Tfam and Nrf1 showed a similar 
pattern of expression, with changes apparent only at 100 
µM lead (Fig. 2C). In order to determine whether the 
highest lead concentration affects Pgc1α expression at 
an early exposure time point, Pgc1α mRNA levels were 
investigated after a 3-hour lead exposure. Surprisingly, 
the expression of Pgc1α mRNA levels was markedly 
upregulated 3-hour post-treatment, with a ten-fold 
increase observed at 500 µM (Fig. 2D).  
 
Since no significant difference was observed between 
cells treated with 5 µM and 100 µM in terms of 
disruption of mitochondrial function, ROS generation or 
cell death(Fig. 1A-D), but there was a significant 
difference in Pgc1α mRNA levels between the two 
groups, we sought to investigate whether Pgc1α plays a 
protective role against lead insult at 100 µM. To 
interrogate this hypothesis, we produced a stable knock-
down of Pgc1α using a lentiviral shRNA vector. 
Successful knock-down was confirmed by Pgc1α 
mRNA levels(Fig. 2E) and clear downregulation of  
PGC-1α  protein levels, as shown by immunocyto-
chemistry (Supplementary Figure3-S3, A). sh-PGC1α 
transduction did not affect colony formation (Fig. 2E 
and F). FACS analysis of cells stained independently 
with MitoSOX and DiOC6(3) showed that reduction of 
Pgc1α expression renders N27 cells more susceptible to 
lead-induced mitochondrial stress (Fig. 2G, H), with 
morphological characteristics of apoptosis apparent in 
cells treated with 100µM or 500µM lead 
(Supplementary Figure1-S1, B). 
 
The influence of lead treatment on mitochondrial 
organisation was investigated by immunofluorescence 
(Fig. 2I). Exposure to 100 µM lead caused 
mitochondrial filament elongation, while mitochondria 
in cells exposed to 500 µM Pb2+ were very fragmented 
and localized to the nuclear perimeter (Fig. 2I). 
 
An equivocal role of PGC1α in neuroprotection and 
toxicity 
 
To determine whether up-regulation of PGC1α was 
responsible for the changes in mitochondrial 
morphology and organization and subsequent protection 
of DA neurons from lead insult, we examined the 
effects of PGC1α overexpression on the structure of 
mitochondria (Fig. 2J and K) and (Fig. 3A and B). 
Intriguingly, overexpression of PGC1α actually 
increased susceptibility of N27 cells to lead toxicity at 
both 100 and 500 µM, as manifested by increased 
fragmentation of mitochondria, measured as a decrease 
in mitochondrial surface area (Fig. 3A and B).Whereas 
a two-fold increase in PGC1α expression protected cells 
against lead-induced neurotoxicity (endogenous levels 
of the protein doubled in response to 100 µM lead), 
higher expression levels (>50 fold) of the protein had 
the opposite effect and exacerbated the toxicity of lead 
(Fig. 2J and K). Furthermore, cells overexpressing 
PGC1α treated with 100µM and 500µM leaded showed  
condensed nuclei, an apoptotic hallmark  
(Supplementary Figure1-S1, C). 
 
Since exposure to lead induced changes in 
mitochondrial organization, the expression profiles of 
genes encoding proteins regulating mitochondrial 
dynamics were investigated. RT-QPCR analysis 
revealed that 100 µM lead shifts the mitochondrial 
dynamic profile towards fusion (Fig. 3C). While Mfn2 
mRNA levels were increased, the transcript levels of 
Drp1, a fission promoting factor, were significantly 
decreased upon treatment. The Fis1 mRNA expression 
profile remained unchanged. To investigate the role of 
PGC1α alone in regulation of mitochondrial dynamics, 
Drp1 and Mfn1expression levels were investigated in 
PGC1α-overexpressing cells. Levels of Mfn1 expression 
mRNA) were significantly increased whilst those of 
Drp1 were significantly decreased (mRNA and protein) 
(Fig. 3D and Supplementary Figure 3-S3, B). 
 
This suggested that overexpression of PGC1α was 
accompanied by a shift of the mitochondrial dynamics 
profile towards fusion (Fig. 3D). ChIP assay was 
performed to identify regulatory targets of PGC1α. This 
revealed significantly increased binding of PGC1α to its 
own promoter and unexpected binding to the Drp1 
promoter (Fig. 3E). Moreover, PGC1α bound to Nrf1 
and SOD2 promoters.  
 
In order to compare the effect of lead on neuronal cells 
in vitro and in vivo, tissue samples were obtained from 
substantia nigra of rats given drinking water containing 
500 ppm lead acetate for a period of 14 weeks as well as 
from control animals given water with acetate only. 
Real time QPCR analysis showed that Pgc1α mRNA 
levels, as well as levels of its downstream targets (Nrf1, 
Nrf2, Tfam) were significantly increased in the 
substantia nigra of animals exposed to lead (Fig. 4A). 
Expression of both mitofusins was also significantly 
induced by lead (Fig. 4A). Interestingly, unlike N27 
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dopaminergic neurons exposed to lead for 48-hours in 
vitro, levels of theDrp1 transcript were increased together 
with levels of Mfn1 and Mfn2 transcipts, after lead 
exposure in vivo, with no decrease in the number of 
tyrosine hydroxylase-expressing, dopaminergic SN 
neurons cells (Fig. 4B and C). Since SN tissue used in the 
experiment was a heterogeneous mixture of different cell 
types, including neurons, we performed dual fluorescence 
immunohistochemistry of DRP1 and NeuN (a neuronal 
specific marker) in the ventral mesencephalon to 












































in Drp1 expression was specific to DA neurons (Fig. 
4D). Further analysis confirmed that the expression of 
DRP1 protein was significantly induced by lead in SN 
pars compact a neurons only (Fig. 4E). As adult rats are 
less susceptible to lead toxicity than young rats, and a 
significant increase of Drp1 expression was observed in 
vivo at 48-hours, we looked at Drp1 expression in vitro 
after short-term exposure (Fig. 4F). After 3-hours of 
lead exposure in N27 cells, an elevation of Drp1 mRNA 

















































(b),  Pb2+  500µM  (c)  and  PGC1α  overexpression  alone  (d)  or  combined with  Pb2+  100µM  (e)  or  500  µM  (f) was
measured  by  Spectrum.  (A,  a’‐f’)  mitochondrial  area  surface  determined  using  ImageJ‐>threshold‐





































































































































mM N‐acetylcysteine (NAC) for 1 hour followed by a 48‐hours  lead‐exposure was used to  investigate the  impact on
mitochondrial ROS  (A) and mitochondrial depolarisation  (MMP)  (B) N27  cells  treated with  lead  for 48‐hours were
tested  for  cytoplasmic  (C)  and  ER  calcium  levels  (D) using  thapsigargin  (Tg)  and Rhod‐2  staining  followed by  flow
cytometry  analysis  (D,  a  and b). Calcineurin  transcript  levels 48‐hours post‐lead exposure were  investigated using
qRT‐PCR  (E). Pre‐treatment of N27 cells with 5µM BAPTA‐AM for 1 hour followed by a 48‐hours  lead‐exposure was
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Lead treatment causes a disruption of cellular 
calcium balance 
 
The possible role of ROS in lead-induced cell death in 
N27 cells was investigated using N-acetylcysteine 
(NAC), a well-known ROS scavenger. However, NAC 
pre-treatment of cells had no effect on lead-induced 
changes in mitochondrial ROS or membrane potential 
(Fig.5A and B). Therefore, we explored the possibility 
that changes in intracellular Ca2+ levels might mediate 
the effects of lead, since lead is known to mimic this 
cation inside the cell and compete with it for binding to 
Ca2+-dependent proteins. Moreover, calcium-regulated 
proteins have been shown to play a role in control of 
PGC1α expression [19]. 
 
Staining of cells with Fluo4-AM, a cytoplasmic calcium 
dye, revealed that lead causes an increase of cytosolic 
Ca2+ with depletion within the ER (Fig. 5C and D). Pre-
treatment of cells with BAPTA-AM, a cytoplasmic 
calcium chelator, conferred protection against lead 
insult (Fig. 5F and G). This finding, together with a lack 
of response to NAC on cellular susceptibility to lead, 
implicates a primary role for calcium in the response of 
dopaminergic neurons to lead. mRNA levels of 
calcineurin, a modulator of a number of key Ca2+ 
signalling pathways in neurons, were significantly 
increased on exposure to higher concentrations of lead, 
with peak expression occurring at 100 µM (Fig. 5E). 
Calcineurin mRNA levels at 100 µM and 500 µM 
mirrored those of Pgc1α and its target genes Nrf1 and 
Tfam (Fig 1A-C).  
 
Caspase-8 cleavage of BAP31 at the ER stimulates 
Ca2+-dependent mitochondrial fission and subsequently 
enhances pro-apoptotic signals between the ER and 
mitochondria [6, 20]. Since the protein level of BAP31 
increased after exposure to 100µM and 500µM lead 
(Fig. 5H), we investigated whether BAP31 down-
regulation had any neuroprotective effect against lead 
insult. shRNA delivered by a lentiviral vector was used 
to knock down Bap31 expression in N27 cells (Fig. 
5I).shRNA-Bap31 conferred significant protection 
against lead toxicity (Fig. 5J-M) implying an important 
role of BAP31 in the response to lead and in calcium 




In this study, we demonstrate for the first time that 
PGC1α regulates both mitochondrial biogenesis and 
dynamics in dopaminergic neurons exposed to 
neurotoxic lead (II) acetate. Despite a 20-fold 
concentration difference between 5µM and 100µM, the 
effects of lead acetate on mitochondrial superoxide 
generation and membrane polarization were 
comparable. As both of these concentrations exhibited 
minimal toxicity, they were classified as tolerated. 
However, at 500 µM, lead had a much more deleterious 
effect on mitochondrial function and subsequently 
induced excessive cell death; therefore this 
concentration was classified as toxic. Interestingly, 
while most parameters of mitochondrial function 
remained unaffected by tolerated concentrations of lead, 
spare respiratory capacity (SRC) was lost at all 
concentrations, a previously unreported effect of lead. 
This finding is consistent with the stochastic 
mitochondrial failure model proposed by Choi, et al. 
[21] to explain the importance of mitochondrial SRC in 
neurodegeneration. SRC is used here to describe the 
amount of extra ATP that can be produced by oxidative 
phosphorylation in case of a sudden increase in energy 
demand. Depletion of the SRC has been related to a 
range of pathologies affecting high energy requiring 
cells such as neurons [21, 22].  
 
As N27 cells were able to tolerate concentrations of 
lead up to a toxic threshold, we suspected the presence 
of a protective mechanism, to help cells survive lead 
insult. PGC1α is a well-established master regulator of 
mitochondrial metabolism [1] and has previously been 
reported to play a protective role against a variety of 
neurodegenerative conditions [23, 24]. PGC1α is also 
known to respond to ROS by inducing a cellular ROS 
scavenging program [25]. Due to these diverse 
functions, we investigated whether PGC1α plays a role 
in the cellular response to lead exposure. Exposure of 
cells to 100 µM lead for 48-hours indeed resulted in 
increased expression of PGC1α and modulation of its 
downstream targets, including genes regulating 
mitochondrial biogenesis. Stable down-regulation of 
Pgc1α expression in DA cells increases their 
vulnerability to lead insult. Thus, we show for the first 
time that exposure to sub-lethal doses of lead induces 
low-level stress, which triggers an adaptive response 
mediated by PGC1α. This supports the hypothesis that 
PGC1α acts to protect the cells by promoting 
mitochondrial biogenesis, boosting their function and 
suppression of ROS [26]. We believe that at low lead 
levels, slightly increased ROS production, which acts as 
a retrograde nuclear signal, can improve mitochondrial 
function with adaptation to the stressor, a phenomenon 
known as mitohormesis [27].  
 
Short exposure (3-hours) to lead induces a significant 
increase of Pgc1α transcript levels at 100µM and 
500µM. However, whereas at 100µM the increase is 
sustained at 48-hours, at 500 µM, levels return 
completely to baseline by this time. Hence, lead 
modulates Pgc1α expression in a dose-and time-
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dependent manner. At toxic doses the adaptive response 
of the cell is initially triggered but becomes overridden 
by the excessive toxicity, such that it is beyond the 
homeostatic ability of the cell to counteract the insult. 
Unexpectedly, overexpression of Pgc1α did not confer 
increased protection against lead, instead, upon 
treatment with lead, cells showed an increased level of 
apoptosis compared with wild-type cells. Thus, the role 
of PGC1α appears to be equivocal: while it helps the 
cell to tolerate a certain level of toxic insult, prolonged 
expression to non-physiological levels has a deleterious 
effect on mitochondrial function and viability of the 
cells. Ciron et al.[28] have previously shown that 
sustained expression of PGC1α in dopaminergic 
neurons leads to neurodegeneration. Therefore, we 
postulate that PGC1α plays a dual role in response to 
the neurotoxicant lead. Increased expression at lower 
concentrations of lead is beneficial as part of an 
adaptive, mitohormetic response, whereas at higher 
concentrations, higher expression levels of PGC1α, 
when sustained for a prolonged period of time, 
characteristic of chronic exposure, lead to lethal 
changes in cellular metabolism.  
  
We have observed that changes in the expression of 
PGC1α result in a structural alteration of mitochondrial 
filaments. There has been little research investigating 
the role of PGC1α in orchestrating mitochondrial 
dynamics. Previously it has been suggested that PGC1α 
promotes mitochondrial fusion via co-activation of 
MFN2expression [29]. Moreover, it has recently been 
shown that PGC1α regulates MFN1.  Martin et 
al.[30]also showed an association between PGC1α/β 
levels and expression of other fission/fusion genes. 
However, these authors did not explore the direct 
interaction between PGC1 proteins and the genes 
mentioned above.  Therefore we investigated the 
expression of a range of genes known to control 
mitochondrial dynamics, upon exposure to lead. In this 
study, we made the novel observation of a PGC1α-
induced decrease in DRP1 expression in vitro, in 
addition to increased levels of MFN2 transcript. It 
appears that the shift of mitochondrial dynamics 
towards fusion, observed at 100 µM lead, is due to a 
change in the transcriptional profile of a number of 
genes controlling this process. A similar effect was seen 
in cells overexpressing PGC1α, confirming the role of 
this transcriptional co-activator in the control of 
mitochondrial dynamics. While in vivo data supported 
the notion of lead increasing the expression of 
mitofusins (MFN1 and MFN2), and so, promoting 
fusion, we also observed an increase of Drp1 mRNA. 
Since substantia nigra obtained from rats, as used in our 
experiments, is a heterogeneous mixture of different 
cells with dopaminergic neurons comprising just 1-2% 
of the total cell population [31], we looked at co-
localization of NeuN and DRP1 in samples to exclude 
the possibility that the global SN mRNA changes 
observed in our experiment interfere with measurements 
of the transcriptional state of dopaminergic neurons.  
 
Having confirmed that Drp1 levels are increased in SN 
neurons, we sought to match an appropriate exposure 
duration in vitro.  Hence, the expression profile of this 
gene was determined in N27 cells following a short 3-
hours exposure to 100 µM lead. Drp1 expression was 
increased after this time, but reduced after 48-hours. 
Hence, this short exposure in vitro could be reflecting 
an early event that happens in DA neurons as protection 
against lead exposure. 
 
ChIP data revealed that PGC1α binds to the promoter of 
Drp1 implying its direct role in regulating the 
expression of this mitochondrial protein. We propose 
that as an initial response to the insult in vivo and in 
vitro, PGC1α levels increase in response to lead, which 
promotes mitochondrial biogenesis. This in turn 
requires an increased expression of proteins regulating 
mitochondrial dynamics. Tight control of this vital 
process is essential to maintain balanced intracellular 
energy distribution and cell viability.  
 
Continuous exposure to tolerated level of lead triggers a 
protective response which involves a non-excessive 
expression of genes regulating mitochondrial dynamics 
with the shift of the balance toward fusion, which has 
been previously shown to help protect against 
neurodegeneration [32]. We believe that while the 
binding of PGC1α to the promoter of Drp1 at lower 
concentrations (100µM) results in an increase in the 
expression of DRP1 to ensure maintenance of fusion-
fission balance in the cell, the transcript levels of Drp1 
remain low at high lead concentrations due to the 
absence of other members of a transcription complex 
driving expression of this gene, lack of transactivation 
or presence of an inhibitor, such as e.g. p160MYB [33].  
  
Whilst evidence was obtained that demonstrates PGC1α 
plays a pivotal role in the response of DA cells to lead, 
it was unclear the mechanisms by which lead and 
PGC1α are inter-linked. One possibility was ROS. 
However, the antioxidant NAC was unable to prevent 
an increase in lead-induced mitochondrial ROS and 
subsequent loss of mitochondrial membrane potential. 
We then focused on calcium, a ubiquitous intracellular 
secondary messenger. Calcium is of particular interest 
due to the ability of lead to mimic this ion in the cellular 
milieu [34]. In the present study, we show that lead 
causes release of ER calcium stores, increase in 
cytoplasmic calcium concentrations, which cause 
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disruption of calcium balance leading to mitochondrial 
dysfunction and DA neuronal cell death. Interestingly, 
calcineurin, the activity of which depends on 
Ca2+/calmodulin binding, can be activated by low 
concentrations of free lead while higher concentrations 
reduce its activity [35]. Our data showed a significant 
increase in calcineurin transcription levels at a tolerated 
concentration of lead (100µM) and a clear decline at the 
toxic concentration (500 µM), an observation consistent 
with the published data.  
 
Disruption of ER calcium stores has previously been 
implied in neurodegeneration [36] and has been 









































causes cognitive dysfunction in neonatal rats [18]. 
Unlike NAC, pre-treatment of dopaminergic cells with 
the calcium chelator BAPTA-AM prevented lead-
induced mitochondrial membrane potential loss and 
subsequent cell death, reflecting the upstream role 
played by this ion in lead toxicity. ER calcium is linked 
to apoptosis by pro-apoptotic Bap20, the cleavage 
product of ER-localized BAP31, which mediates 
mitochondria-ER cross talk through a Ca2+-dependent 
mechanism [37]. Our data showed that stable 
knockdown of BAP31 significantly decreases activation 
of caspase-8 as well as caspase 3/7. Caspase-8 cleavage 
of BAP31 at the ER stimulates Ca2+-dependent 











































Figure 6. Schematic  representation of adaptive  response and neuroprotection  induced by cell‐
tolerated levels of Pb2+. Exposure to non‐cytotoxic levels of lead (100μM) induces an adaptive biological
response.  This  response  involves  ER  calcium  release  and  requires  both  caspase‐8  activation  and  BAP31
cleavage  (1).  Increased  cytoplasmic  levels of  calcium  induce expression and activation of  calcineurin  (2) as
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Interestingly, Breckenridge and co-workers [38]have 
shown that overexpression of Bap20 causes ER Ca2+ 
release and concomitant uptake of Ca2+ into 
mitochondria with subsequent recruitment of DRP1, 
resulting in dramatic mitochondrial fragmentation. Our 
data show that the BAP31 protein increases in a dose 
dependent manner with lead exposure and its 
knockdown reduces lead-induced initiation of the 
mitochondrial cell death pathway. This reveals the 
important role played by this ER protein in disruption of 
calcium homeostasis in response to lead insult. 
Together, our data and those of Brekenridge and co-
workers strongly suggest the involvement of ER 





We show for the first time that low levels of lead cause 
disruption of cellular calcium balance in dopaminergic 
neurons, involving BAP31-mediated ER-mitochondrial 
crosstalk, which induces an adaptive response mediated 
by PGC1α. This effect involves an alteration of 
expression of genes regulating mitochondrial dynamics 
(shown by us to be controlled by PGC1α). We have also 
made the novel discovery that PGC1α is directly 
involved in control of Drp1 expression (Fig. 6). While 
beneficial and protective at physiological levels, it 
appears that long term, chronic stimulation of cells at 
higher concentrations of lead causes sustained 
expression of PGC1α at high levels, leading to 
neurodegeneration via profound remodeling of the 
mitochondrial network and changes in cellular 
metabolism. Moreover, any homeostatic imbalance in 
PGC1α levels (downregulation/overexpression) renders 
DA cells more susceptible to lead insult. We have also 
shown that lead causes loss of SRC which renders the 
cells more susceptible to degeneration when subject to 
an increased energy demand.  
 
This study provides evidence that the maintenance of a 
homeostatic PGC1α expression level is essential for 
protection of neuronal cells against lead insult. 
 
MATERIALS AND METHODS 
 
Cell culture and treatments. Rat mesencephalon-derived 
cell line (1RB3AN27; hereafter referred to as N27 
cells)represent a homogenous population of tyrosine 
hydroxylase-expressing cells with functional 
characteristics resembling dopaminergic neurons.  N27 
cells were maintained in RPMI-1640 medium 
supplemented with 10% FBS, 100 U/ml penicillin and 
100 µg/ml streptomycin (Sigma) at 37°C in a 5% CO2 
humidified atmosphere. Cells were exposed to lead (II) 
acetate (Sigma) dissolved in distilled water added to the 
growth medium at 5, 100 and 500 µM for 48-hoursor 3- 
hours, as indicated.  
 
Stable cell line production. The pLKO.1-TRC cloning 
vector was obtained from AddGene. Oligonucleotides 
containing shRNA were cloned into the vector 
according to the manufacturer’s protocol. For shRNA 
primers used for PGC1α and BAP31 see 
Supplementary Material Table 1. 
 
Virions were produced in HEK293T cells, by 
combining three packaging plasmids (pVSV-G), pRev, 
pGag.Pol (Invitrogen) with pAdVantage (Promega), and 
pLKO vector. Water and 2 M CaCl2 were added and 
complexes were mixed with 2× HBS (500 μl) and added 
to cells drop wise. After an overnight incubation, fresh 
DMEM medium containing 1 mM sodium butyrate was 
added. Post-transfection the supernatant was collected, 
spun down and filter-sterilized. N27 cells were 
transduced for 8-hours in the presence of polybrene 
(Sigma). Cells were selected with puromycin 3 days 
after transduction. 
 
Successful knockdown was confirmed by the reduction 
in specific mRNA (Fig. 2E and protein, as determined 
immunocytochemically (Supplementary figure3-S3, A). 
 
Caspase activity measurement. Caspase activity assays 
were performed using CaspaTag™ caspase-3/7 or 8 
assay kit (Millipore) according to the manufacturer's 
protocol followed by data collection with 
FACSCalibur™ (BD Biosciences) and analysis with 
Cyflogic (CyfLo Ltd.) 
 
Mitochondrial superoxide measurement. Mitochondrial 
superoxide levels were measured using MitoSOX™ 
Red (Invitrogen) according to the manufacturer’s 
guidelines. FACSCalibur™ (BD Biosciences) was used 
for data collection and Cyflogic (CyfLo Ltd.) for the 
analysis. 
 
Mitochondrial membrane depolarisation. Cells were 
harvested as described above and resuspended in 150 µl 
of PBS containing 40 nM 3,3-dihexaoxacarbocyanine 
iodide (DiOC6) and PI (50 μM) for 40 minutes at 37°C. 
Cells were then analysed using FACSCalibur™.  
 
RNA extraction from cells. Total RNA extraction was 
performed using QiaShredder columns and the RNeasy 
extraction kit (Qiagen).  
 
Animals and surgery. Twenty male albino Wistar rats 
(250-270 g) were kept at constant room temperature of 
22 ± 1 ºC and relative humidity (60%) with a 12-h light-
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dark cycle (8:00 a.m.-8:00 p.m.), with free access to 
food and water containing either sodium lead acetate 
(500 ppm) or sodium acetate for 14 weeks. Then, half of 
the animals in each group were killed by decapitation 
(RT-PCR experiments) or by perfusion (immunohisto-
chemistry experiments).  
 
Fluorescence immunohistochemistry. Thaw-mounted 
20-μm coronal sections were cut on a cryostat at –15 ºC 
and mounted in gelatin-coated slides. For double-
labelling of DRP1 with NeuN, sections were blocked 
with PBS containing 1% normal goat serum and horse 
serum (Vector) for 1 h. The slides were washed three 
times in PBS and then incubated overnight at 4ºC with 
either rabbit-derived anti-DRP1 (1:300; Cell Signalling) 
or mouse-derived anti-NeuN (1:1000; Millipore) diluted 
in PBS containing 1% normal goat/horse serum and 
0.25% Triton X-100. Sections were incubated with goat 
anti-rabbit secondary antibody conjugated to fluorescein 
(1:200, for DRP1; Vector) and horse anti-mouse 
secondary antibody conjugated to Texas Red (1: 200, 
for NeuN; Invitrogen) for 1 h. Nuclei were 
counterstained with Hoechst (1 µg ml−1, Molecular 
Probes). Fluorescence images were acquired using a 
confocal laser scanning microscope (Zeiss LSM 7 
DUO) and processed using the associated software 
package (ZEN 2010). Signal intensity was quantified 
using an Image Analysis Program from Soft Imaging 
System (analySIS®, Germany). 
 
Stereological counting of TH-positive neurons in SN. 
The number of TH-positive neurons in the SN was 
estimated using a fractionator sampling design. Counts 
were made at regular predetermined intervals (x = 150 
μm and y = 200 μm) within each section. An unbiased 
counting frame of known area (40 × 25 μm = 1000 μm2) 
was superimposed on the tissue section image under a 
100× oil immersion objective. Therefore, the area 
sampling fraction is 1000/(150 × 200) = 0.033. The 
entire z-dimension of each section was sampled; hence, 
the section thickness sampling fraction was 1. In all 
animals, 20-μm sections, each 100 μm apart, were 
analyzed; thus, the fraction of sections sampled was 
20/100 = 0.20. The number of neurons in the analyzed 
region was estimated by multiplying the number of 
neurons counted within the sample regions by the 
reciprocals of the area sampling fraction and the 
fraction of section sampled[39]. 
 
RNA extraction from tissue. Rat substantia nigra were 
dissected with reference to a standard rat brain atlas 
(Paxinos and Wilson, 6th Edition, Elsevier), 
immediately snap-frozen in liquid nitrogen and stored at 
-80C. Total RNA was extracted using the phenol-
chloroform method.  Ice-cold Trizol reagent (Life 
Technologies) was added to 25-50mg of sample 
according to the manufacturer’s instructions. Brain 
tissue kept on ice was homogenized using a tissue 
homogenizer (OMNI international).  
 
Real-time PCR. Five µg RNA was used to synthesize 
cDNA using the ThermoScript™ RT-PCR first strand 
synthesis system (random hexamer method) according 
to manufacturer’s instructions (Invitrogen). Platinum 
SYBR Green qPCR Super Mix-UDG (Invitrogen) was 
used for qPCR analysis. Primers were designed using 
Primer Blast (supplementary data, table 1). Real time 
PCR reactions were performed using Stratagene 
Mx3000P instrument. MxPro Software (Stratagene) was 
used to obtain Ct values. Transcript levels relative to 
GAPDH were determined using the standard curve 
method. 
 
Mitochondrial function assessment. The Seahorse XF 
analyzer was used according to manufacturer’s 
guidelines (Seahorse Bioscience). OCR values were 
measured by XF24 extracellular flux analyzer.  
 
Immunocytochemistry. Cells were stained with 
MitoTracker Red (Molecular probes) according to the 
manufacturer’s protocol, fixed with 4% 
paraformaldehyde and blocked in 10mM HEPES, 0.3% 
TX-100, 3% BSA, pH 7.4 for 1 hour at RT. Coverslips 
were subsequently incubated with PGC1α antibody 
(overnight; Everest) and AlexaFluor 488 anti-goat IgG 
secondary antibody (RT, 1 h; Molecular Probes). Nuclei 
were counterstained with Hoechst (Molecular Probes). 
 
Western blot analysis. Cells were homogenized on ice 
in lysis buffer (1 M Tris-HCL, 2.5 M NaCl, glycerol, 
0.5 M β-glycerophosphate, Tween 20 and Nonidet P40). 
The lysate was cleared by centrifugation at 900 g for 10 
min at 4 °C. 50-120 µg of proteins were run on a 10% 
SDS-PAGE gel and transferred to nitrocellulose 
membranes (GE healthcare). Membranes were blocked 
with 5% non-fat dry milk dissolved in PBS with 0.01% 
Tween 20 (Sigma). Incubation with primary antibodies 
was performed overnight at 4°C (see supplementary 
materials for the antibody list).  Peroxidase activity was 
developed using enhanced chemiluminescence (ECL).  
 
Chromatin immunoprecipitation. N27 cells were treated 
and fixed with formaldehyde and quenched with 
glycine. Chromatin immunoprecipitation of samples 
was performed as described previously [40] using 
PGC1α antibody, followed by Q-RT-PCR analysis. An 
irrelevant goat antibody (IgG) was used as a negative 
control, to control for the possibility of non-specific 
clumping of chromatin. Ct values were normalised 
according to the following equation: ∆Ct[normalised 
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ChIP] = (Ct[ChIP] – (Ct[input] – log2 (0.1))). The % 
input was calculated with the following equation: % 
input = 2(-∆Ct[normalised ChIP]). For the list of target promoter 
primer pairs see supplementary materials. PGC-1α 
binding sites were all within promoter regions, defined 
as ±3 kb from a transcriptional start site (TSS). (Please 
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Supplementary  Figure  1‐S1.  Assessment  of  apoptotic  cell  death  induced  by  lead.(A‐a)  FCAS  analysis  of
caspases3/7 and caspase 8 activation in N27 cells exposed to 100µM and 500µM lead. (A‐b) Representative FACS histogram
of caspases3/7 and caspase 8 activation.  (B) Confocal mycroscopy analysis of morphological features of apoptotic cells  in








































































































of mitochondrial depolarisation  [MMP  (Δψm)  loss], mitochondrial ROS generation and cell death  in N27 cells  treated with
lead for 48‐hours. (B) Scramble and   shRNA PGC1‐α  cells were treated with 100µM of  lead for 48‐hours and mitochondrial
ROS generation  and MMP (Δψm) loss were analysed  by FACS. (C) N27 cells treated with lead for 48‐hours were tested for





































1α   knock‐down  (sh‐PGC1α)   cells compared with  the scramble cells.  (B) Western blot analysis of  transfected cells
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